Patricia Bruijning-Verhagen
@pbruijning.bsky.social
Prof. of Vaccination and Infection Control Epidemiology @UMCUtrecht, the Netherlands
The consistency of the findings across many different subgroups, ages and vaccine doses further reduces uncertainty on the safety of COVID-19 vaccines with respect to mortality risk.
December 12, 2024 at 1:58 PM
The consistency of the findings across many different subgroups, ages and vaccine doses further reduces uncertainty on the safety of COVID-19 vaccines with respect to mortality risk.
This is particularly relevant for LMIC where the costs of PCV vaccines is a major hurdle. But it also reopens the discussion on whether reduced schedules of 1+1 can be considered for infant schedules in the higher valent pneumococcal vaccines now used in many HICs
December 2, 2024 at 6:01 PM
This is particularly relevant for LMIC where the costs of PCV vaccines is a major hurdle. But it also reopens the discussion on whether reduced schedules of 1+1 can be considered for infant schedules in the higher valent pneumococcal vaccines now used in many HICs
Contact your GP or local health authority for this. Unfortunately the costs of vaccination (around 200 Eur) are not covered by the health insurance.
December 1, 2024 at 3:59 PM
Contact your GP or local health authority for this. Unfortunately the costs of vaccination (around 200 Eur) are not covered by the health insurance.
Pregnant women who wish to protect their newborn for this coming season can consider the maternal vaccine Abrysvo if their due date is before March 2025 (typically the end or RS season). www.rivm.nl/rs-virus/rsv...
Prik tegen RS-virus tijdens de zwangerschap
Pasgeboren baby’s kunnen ernstig ziek worden door het RS-virus Respiratoir Syncitieel-virus (Respiratoir Syncitieel-virus) (RSV Respiratoir Syncytieel Virus (Respiratoir Syncytieel Virus)). Zwangeren ...
www.rivm.nl
December 1, 2024 at 3:59 PM
Pregnant women who wish to protect their newborn for this coming season can consider the maternal vaccine Abrysvo if their due date is before March 2025 (typically the end or RS season). www.rivm.nl/rs-virus/rsv...
Several European countries now offer infant protection against RS illness through maternal vaccination or monoclonal antibodies for newborns. Netherlands will implement as of season 2025/26.
December 1, 2024 at 3:59 PM
Several European countries now offer infant protection against RS illness through maternal vaccination or monoclonal antibodies for newborns. Netherlands will implement as of season 2025/26.